Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11523424 | PMC |
| http://dx.doi.org/10.1016/j.jvsv.2024.101840 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring Neurohormonal Modulation by Acetazolamide in Heart Failure.
Cureus
December 2024
Gastroenterolgy, Sindh Institute of Urology and Transplantation, Karachi, PAK.
Background Heart failure (HF) is commonly managed by addressing water and sodium (Na) balance, with arterial circulation playing a major role in influencing renal Na and water excretion. Recently, chloride (Cl) has been recognized as an important factor in HF, associated with volume regulation and its modulation of renin-angiotensin-aldosterone system (RAAS) activity through macula densa signaling, which impacts Na retention and neurohormonal activation. Acetazolamide, a carbonic anhydrase inhibitor, can enhance decongestion in HF by increasing urinary Na and Cl excretion when added to loop diuretics, a mechanism supported by prior studies demonstrating improved urine output and decongestion.
View Article and Find Full Text PDFDemystifying Volume Status: An Ultrasound-Guided Physiologic Framework.
Chest
January 2025
Department of Medicine, University of British Columbia. Electronic address:
Topic Importance: Accurate assessment of a patient's volume status is crucial in many conditions, informing decisions on fluid prescribing, vasoactive agents, and decongestive therapies. Determining a patient's volume status is challenging, due to limitations in examination and investigations and the complexities of fluid homeostasis in disease states. Point-of-care ultrasound (POCUS) is useful in assessing hemodynamic parameters related to volume status, fluid responsiveness, and fluid tolerance.
View Article and Find Full Text PDFComplex Decongestive Therapy Improves Gait Speed in Patients with Lower Limb Lymphedema.
Lymphat Res Biol
December 2024
Department of Physical Medicine and Rehabilitation, Ankara City Hospital, Ankara, Turkey.
Secondary lymphedema is acquired and caused by obstruction or injury to a normally developed lymphatic system. Loss of mobility is a common problem in patients with secondary lower limb lymphedema (LLL) following cancer treatment. In this study, we examined the effect of complex decongestive therapy (CDT) on motor function and mobility in patients with LLL.
View Article and Find Full Text PDFInterventions for Prevention and Management of Gynecological Cancer-Related Lower Limb Lymphedema: A Systematic Scoping Review.
Semin Oncol Nurs
December 2024
Koç University School of Nursing, İstanbul, Turkey; University of Massachusetts Amherst College of Nursing, Amherst, Massachusetts.
Objectives: This scoping review aims to map out evidence on interventions for reducing lower limb lymphedema incidence and symptoms after gynecological cancer surgery.
Methods: This scoping review followed the methods and protocol outlined by the Joanna Briggs Institute Methods Manual. Five databases, including Pubmed, Scopus, Web of Science, CINAHL, and PsycINFO were searched in January 2024.
Effects of complex decongestive physical therapy on upper limb circumference and sensory function in post-mastectomy lymph oedema, A quasi-experimental study.
J Pak Med Assoc
December 2024
Riphah International University, Lahore, Pakistan.
The quasi-experimental study was conducted at the Allied Hospital, Faisalabad to investigate the effect of complex decongestive physical therapy on sensory testing in postmastectomy- related lymphoedema patients. The sample comprised 18 participants enrolled using convenience sampling technique. All the participants received complex decongestive physical therapy during 5 sessions per week for 3 weeks.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!